Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults. by Bjarnason, A et al.
ORIGINAL ARTICLE
Utility of oropharyngeal real-time PCR for S. pneumoniae
and H. influenzae for diagnosis of pneumonia in adults
A. Bjarnason1,2 & M. Lindh3 & J. Westin3 & L.-M. Andersson3 & O. Baldursson2 &
K. G. Kristinsson1,2 & M. Gottfredsson1,2,4
Received: 29 August 2016 /Accepted: 20 October 2016 /Published online: 7 November 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract A lack of sensitive tests and difficulties obtaining
representative samples contribute to the challenge in identify-
ing etiology in pneumonia. Upper respiratory tract swabs can
be easily collected and analyzed with real-time PCR (rtPCR).
Common pathogens such as S. pneumoniae and H. influenzae
can both colonize and infect the respiratory tract, complicating
the interpretation of positive results. Oropharyngeal swabs
were collected (n = 239) prospectively from adults admitted
to hospital with pneumonia. Analysis with rtPCR targeting
S. pneumoniae and H. influenzae was performed and results
compared with sputum cultures, blood cultures, and urine an-
tigen testing for S. pneumoniae. Different Ct cutoff values
were applied to positive tests to discern colonization from
infection. Comparing rtPCR with conventional testing for
S. pneumoniae in patients with all tests available (n = 57) re-
sulted in: sensitivity 87 %, specificity 79 %, PPV 59 % and
NPV 94 %, and for H. influenzae (n = 67): sensitivity 75 %,
specificity 80 %, PPV 45 % and NPV 94 %. When patients
with prior antimicrobial exposure were excluded sensitivity
improved: 92 % for S. pneumoniae and 80 % for
H. influenzae. Receiver operating characteristic curve analysis
demonstrated for S. pneumoniae: AUC = 0.65 (95 % CI 0.51–
0.80) and forH. influenzae: AUC = 0.86 (95 % CI 0.72–1.00).
Analysis of oropharyngeal swabs using rtPCR proved both
reasonably sensitive and specific for diagnosing pneumonia
caused by S. pneumoniae andH. influenzae. This method may
be a useful diagnostic adjunct to other methods and of special
value in patients unable to provide representative lower air-
way samples.
Introduction
The microbial etiology of pneumonia often remains undetect-
ed despite extensive diagnostic testing [1]. Blood cultures lack
sensitivity and obtaining representative lower respiratory tract
samples can be challenging [2]. An etiologic diagnosis allows
targeted antimicrobial treatment, a matter of increasing impor-
tance as resistance rates increase [3].
Streptococcus pneumoniae (SP) and Haemophilus
influenzae (HI) are common causes of pneumonia but also
colonize the upper respiratory tract at rates ranging from 1 to
76%, highest in young children [4–6]. Lower respiratory tract
samples such as sputum are thus preferred for diagnostic
purposes.
Multiplex real-time PCR (rtPCR) panels have become
established in the diagnosis of respiratory tract infections but
primarily used to identify viruses and Batypical^ bacteria [7].
Due to easily collected samples and the high sensitivity of
PCR-based methods, upper airway sampling is often used
even when a lower respiratory tract infection is suspected.
The likelihood of a causal association is high if an organism
not known to colonize the respiratory tract is detected in the
setting of pneumonia.
Sputum and nasopharyngeal samples have been examined
with PCR targeting SP and HI applying quantitative thresh-
olds to discern infection from carriage [8–10]. However,
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analyzing sputum does not avoid the problems associated with
obtaining high quality samples [9, 11]. Despite closer anatom-
ical proximity to the site of infection, and study results sug-
gesting lower carriage rates in this area, studies examining
oropharyngeal sampling in pneumonia are lacking [12, 13].
The authors are not aware of any previous studies examin-
ing the utility of rtPCR examining HI from the oropharynx or
Spn9802 as a target for SP in the setting of pneumonia.
Different PCR targets for SP have been proposed but prob-
lems with specificity can occur [13, 14].
The aim of this study was to examine the utility of rtPCR
from oropharyngeal swabs for the etiologic diagnosis of pneu-
monia caused by SP and HI in adults by comparing rtPCR
results with other, established etiological tests and applying
different cycle threshold (Ct) cut-off values to quantitatively
differentiate carriage from infection.
Materials and methods
Patient inclusion and etiological testing
Data was derived from patients admitted with pneumonia
from December 2008 to November 2009 to Landspitali
University Hospital, Reykjavik, Iceland [15]. All participants
had a new chest X-ray infiltrate and clinical symptoms of
pneumonia [16]. Patients with hospital-acquired pneumonia
were excluded. Cultures were collected prior to antibiotic ad-
ministration in hospital. Only high quality sputumwas includ-
ed [17]. Blood cultures were collected, incubated and cultured
using standard methods at our center and susceptibility testing
performed using the Clinical and Laboratory Standards
Institute methods and criteria [18]. Urine antigen testing
(UAT) for SP was performed using a commercially available
kit (Binax NOW Streptococcus pneumoniae). An oropharyn-
geal swab sample (sterile rayon tipped swabs, COPAN Italia)
was collected for rtPCR. Pneumonia Severity Index (PSI) and
CURB-65 scores were calculated [19, 20]. Participant report-
ed antimicrobial use during the 14 days prior to admission was
recorded.
Real-time PCR
Nucleic acid from 200 μL specimens was extracted with
QIAmp DNA Blood Mini Kit (QIAGEN) and the MagNa
Pure Compact Nucleic Acid Isolation Kit I (Roche
Diagnostics). The nucleic acids were eluted in 100 μL vol-
ume, and 5 μL used for rtPCR. RtPCR was performed with an
ABI 7900 384-well system (Applied Biosystems, Foster City,
CA, USA) in eight parallel 20 μL reactions containing
Universal Mastermix (ABI), including oligonucleotides
targeting the omp6 gene of HI and the Spn9802 fragment of
SP. Abdeldaim et al. utilized the same targets [21, 22], but in
order to obtain shorter amplicons and greater specificity new
primers and probes were designed. For both bacteria primers
were altered to decrease amplicon length compared with the
referenced method to achieve a more effective PCR. For HI
two mismatches for Haemophilus haemolyticus were intro-
duced in the probe to increase specificity. The specificity of
rtPCR for SP and HI was tested using reference samples con-
taining Streptococcus mitis, Streptococcus oralis and
Streptococcus sanguinis, and H. haemolyticus and
Haemophilus parainfluenzae respectively. No cross reaction
was noted with either comparison.
Thus, the omp6 gene of HI was amplified by forward prim-
er CTAACAACGATGCTGCAGGCA, reverse primer
GTGTTATAACGTTGTTGAAGATCAGC and probe,
NED-ATGGTGCTGCTCAAA-MGB (MGB, minor groove
binder); and the Spn9802 fragment of SP with forward primer
TTTCTGGATAGAGGGAGTATCCGA, reverse primer
TTACCAACCTACTCATCTTCTCACCA, and probe FAM-
CAAAGTTAATACCGCCCTC-MGB. After a reverse tran-
scription step at 46 °C for 30 min followed by 10 min of
denaturation at 95 °C, 45 cycles of two-step PCR was per-
formed (15 s at 95 °C, 60 s at 58 °C). A pUC57 plasmid
carrying target sequences was used in each run parallel with
patient specimens to verify the performance of PCR (master
mix control). In addition, one positive control was processed
with each set of samples, from extraction of nucleic acids
through the detection of amplified products.
Comparison of different tests
Sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) of rtPCR for SP and HI were
calculated using combined and separate results from sputum
(SP and HI) and blood cultures (SP only), and urine antigen
analysis (SP only) as a reference Bgold standard^. For each
comparison, only participants with both rtPCR results and the
reference test in question available were included. Four differ-
ent threshold cycle (Ct) cutoffs were applied. For these calcu-
lations we assumed that a positive culture or urinary antigen
test indicated a definite etiologic diagnosis while cases with
positive rtPCR but negative comparative tests indicated
colonization.
Statistical analysis
Data for SP and HI were summarized using receiver operating
characteristic (ROC) curves to determine diagnostic efficacy
of the rtPCR for different Ct values. Positive rtPCR results
were examined and true positives determined using culture
or UAT. AUC with 95 % confidence intervals (CI) were de-
termined and optimal Ct cut off determined.
Categorical data was compared using chi-square or
Fisher’s exact test as appropriate. Statistical significance was
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set at two-tailed P = 0.05. Continuous data was compared
using 95 % CI. Calculations were performed using IBM
SPSS Statistics Version 22.0.0.0.
The Landspitali University Hospital ethics committee ap-
proved this study which is in accord with the revised Helsinki
Declaration. All patients or proxy provided written informed
consent.
Results
The study cohort is described in Table 1. In all 373
pneumonia cases were included but complete sample
sets were not universally available. Differences in demo-
graphics, disease severity and outcomes between groups
providing different samples were analyzed. Availability
of PCR swabs was associated with a lower likelihood of
ICU care (5.4 vs. 14.2 %, p < 0.01) and lower 30-day
mortality (2.1 vs. 9.0 %, p < 0.01) (Table 1).
Rates of SP and HI identification
SP was identified with conventional methods in 30 (12.6 %)
and HI in 17 (7.1 %) of 239 patients with rtPCR results avail-
able, compared with 22 (16.4 %) and 4 (3.0 %) of 134 patients
without rtPCR results, differences that were not statistically
significant. Using rtPCR, SP was identified in 61 (25.5 %)
cases and HI in 50 (20.9 %). Rates of positive rtPCR were
similar in patients with sputum culture, blood culture or UAT
results available (Table 2).
Sensitivity and specificity of real-time PCR
For SP overall sensitivity was 87 %, specificity 79 %, PPV
59 % and NPV 94 % amongst patients with all tests available.
Results were similar when UAT results were excluded from
the analysis. For HI sensitivity was 75 %, specificity 80 %,
PPV 45 % and NPV 94 %. Excluding patients with recent
antibiotic use increased the sensitivity of rtPCR for both SP
and HI (Table 3).
When single tests were compared with rtPCR, sensitivity
and specificity for SP were similar for sputum and blood cul-
ture while sensitivity was decreased when compared with
UAT. A similar comparison was not possible for HI due to
lack of positive blood cultures (Table 3).
The ROC curves for SP and HI are shown in Fig. 1. The
AUC for SP was 0.65 (95 % CI 0.51–0.80) with an estimated
optimal cutoff Ct value of 35 cycles. ROC analysis for HI
resulted in an AUC of 0.86 (95 % CI 0.72–1.00) with an
estimated optimal Ct cutoff of 33. T
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Discussion
This study is the first to examine oropharyngeal rtPCR for HI
and target SP with Spn9802 to diagnose pneumonia. Samples
from a prospective cohort of consecutive patients requiring
hospital admission for pneumonia with a high rate of patient
inclusion (95 %) were examined. SP and HI were detected
using conventional methods in 14 and 6 % of patients, similar
to previous reports [1, 13]. Sensitivity of tests in increasing
order were blood culture, UAT (SP only), and sputum culture
(Table 2) [23]. The sensitivity of sputum culture is offset by
decreased specificity due to risk of contamination from upper
airway colonization.
Performance of real-time PCR
In cases with complete test panels, sensitivity and specificity
of rtPCR for SP was 87 and 79 % (Table 3). In comparison, a
recent meta-analysis estimated the sensitivity and specificity
of UAT for SP to be 69 and 84 % [24]. Allowing incomplete
test panels decreased sensitivity, possibly due to false negative
results. For HI the sensitivity and specificity were 75 and
80 %. This comparison uses sputum culture for reference as
HI was not isolated from blood in any of the included samples.
The PPV for SP was 59 % and NPV 94 % for complete
sample sets, and the results for HI were 45 and 94%. PPVwas
improved for both pathogens by excluding rtPCR positive at
high Ct values, representing less DNA in the initial sample
(Table 3). These results may be compared with 91–95 % PPV
and 83–91 % NPV for UAT described previously [25, 26].
RtPCR provides quantitative information in the form of Ct
values, which may assist in discerning colonization from in-
fection [27]. ROC analysis indicated good accuracy for HI
(AUC = 0.86) but relatively poor for SP (AUC = 0.65).
Results for rtPCR were improved among patients without
prior antibiotic use (Table 3) indicating use of antimicrobials
prior to admission may have negatively affected the ROC
result.
Potential impact of cross-reactivity and carriage
on specificity
Cross-reactivity with other species may decrease PCR speci-
ficity. The pneumolysin gene (ply) target for SP may react
with alpha-hemolytic streptococci [9, 28]. Targeting the
autolysin gene (lytA) or Spn9082 may offer higher specificity
but lytA is also present in other streptococci from the oral flora
while the Spn9802 PCR may react to Streptococcus
pseudopneumoniae [28]. The clinical significance and possi-
ble occurrence of S. pseudopneumoniae carriage is unclear.
Targeting the Spn9802 region may lead to more specific re-
sults but has not been utilized in a clinical study of pneumonia
etiology to the authors’ knowledge.
The P6 gene has been shown to be a sensitive and specific
PCR target for identifying HI [21]. While possible cross-
reactivity with related species has been demonstrated, the clin-
ical significance is unclear, a problem compounded by diffi-
culties in discriminating some of these species using conven-
tional methods [29].
As this study did not include a control group background
carriage in the population is difficult to assess. Two studies
performed in a Nordic setting examined nasopharyngeal cul-
tures from adults with non-infectious conditions at healthcare
centers and hospitals and found low carriage rates, i.e. 1–3 %
for both SP and HI [5, 8]. Carriage rates increased to 3 and 2%
with PCR analysis [8]. A more recent study examining oro-
pharyngeal samples from community dwelling seniors detect-
ed SP in 5 % with culture but 18 % with PCR [30]. However,
this study targeted ply which may have led to false positive
Table 2 Comparison of detection
rates for S. pneumoniae and
H. influenzae with real-time PCR
and conventional testinga among
patients with both tests available
Measure No. with test available:
Sputum culture Blood culture Urinary antigen testb
(n = 83) (n = 187) (n = 168)
S. pneumoniae identified with:
Conventional method, no. (%) 17 (20) 5 (3) 21 (13)
Real-time PCRc, no. (%) 29 (35) 45 (24) 50 (29)
H. influenzae identified with:
Conventional method, no. (%) 12 (16) 0 (0)
Real-time PCRc, no. % 24 (29) 40 (21)
UAT urinary antigen test
a Patients with both real time PCR result and relevant alternative test examined for each type of test. Patients could
be included in more than one group when multiple cases were available
b UAT is not available for detection of H. influenzae
c Real-time PCR considered positive at Ct of 45 or below
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test results due to cross-reactivity with alpha-hemolytic strep-
tococci in the oropharynx [28].
Comparison with previous studies
In addition to alternative PCR targets, differences in setting
and study populations hamper comparison with older studies.
Yang et al. examined sputum samples in pneumonia and de-
termined a sensitivity of 90 %, specificity of 80 % and an
AUC of 0.87 for identifying SP [9]. It is perhaps not surprising
that examining lower respiratory tract samples in a selected
cohort of patients would result in a higher AUC. The selected
PCR target (ply) may also partially explain the higher sensi-
tivity and lower specificity of these results compared with the
present study [14].
Strålin et al. compared PCR for SP (lytA) and HI (16sRNA
with P6 verification) of sputum and nasopharyngeal samples
with a composite of reference tests in pneumonia patients.
Among patients without prior antibiotic use they found that
sputum PCR had a sensitivity of 92 % and specificity of 42 %
while nasopharyngeal swabs had a sensitivity of 61 % and
specificity of 87 % for SP while the sensitivity for HI was
Table 3 Sensitivity, specificity,
positive predictive value and
negative predictive value of PCR
identification of S. pneumoniae
and H. influenzae from upper
airway swabs positive at varying
Ct value cutoffs compared with
different reference gold standards
Cta S. pneumoniae H. influenzae
Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV
Sputum culture (n = 83)
All 82 % 77 % 48 % 94 % 79 % 81 % 46 % 95 %
40 82 % 79 % 50 % 95 % 79 % 93 % 69 % 96 %
35 59 % 89 % 59 % 89 % 57 % 100 % 100 % 92 %
30 41 % 97 % 78 % 86 % 21 % 100 % 100 % 86 %
Blood culture (n = 187)
All 80 % 77 % 9 % 99 % –* 79 % 0 % 100 %
40 80 % 79 % 10 % 99 % – 88 % 0 % 100 %
35 40 % 88 % 8 % 98 % – 95 % 0 % 100 %
30 40 % 95 % 18 % 98 % – 99 % 0 % 100 %
Urinary antigen testb (n = 168)
All 67 % 77 % 28 % 95 % – – – –
40 67 % 79 % 30 % 95 % – – – –
35 48 % 87 % 33 % 93 % – – – –
30 24 % 96 % 42 % 90 % – – – –
SC, BC and UAT, any availablec (SP n = 228; HI n = 214)
All 70 % 81 % 36 % 95 % 79 % 82 % 23 % 98 %
40 70 % 83 % 38 % 95 % 79 % 92 % 39 % 98 %
35 47 % 91 % 44 % 92 % 57 % 98 % 62 % 97 %
30 27 % 97 % 62 % 90 % 21 % 99 % 75 % 95 %
SC, BC and UAT, all availablec (SP n = 57 & HI n = 67)
All 87 % 79 % 59 % 94 % 75 % 80 % 45 % 94 %
40 87 % 81 % 62 % 94 % 75 % 91 % 64 % 94 %
35 53 % 86 % 57 % 84 % 25 % 100 % 100 % 86 %
30 40 % 95 % 75 % 82 % 17 % 100 % 100 % 85 %
SC, BC and UAT, all available, patients with prior antibiotics excludedc (SP n = 37 & HI n = 47)
All 92 % 80 % 69 % 95 % 80 % 84 % 57 % 94 %
40 92 % 84 % 73 % 95 % 80 % 92 % 73 % 94 %
35 58 % 92 % 78 % 82 % 60 % 100 % 100 % 90 %
30 42 % 96 % 83 % 77 % 20 % 100 % 100 % 82 %
Ct threshold cycle, PPV positive predictive value, NPV negative predictive value, SC sputum culture, BC blood
culture, UAT urinary antigen test
a Ct is a semi quantitative measurement which relates inversely to the samples’ initial DNA concentration
bNo patients were positive for H. influenzae in blood culture
c UAT not available for H. influenzae, thus not included in right columns
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78 and 80 % [8]. Aside from a slightly higher sensitivity for
SP from sputum it is of interest that utilizing sputum and
nasopharyngeal samples were not necessarily superior to oro-
pharyngeal swabs for diagnosing pneumonia.
Albrich et al. applied quantitative rtPCR (lytA) to examine
nasopharyngeal swabs in adult HIV positive pneumonia pa-
tients with good results. The sensitivity was 82 % and speci-
ficity was 92% for discerning infection from colonization and
the AUC 0.78 for identifying SP. These results are similar to
the present study but are difficult to compare due to differ-
ences in setting and population [31].
Abdeldaim et al. applied PCR targeting omP6 (HI) to na-
sopharyngeal aspirates from 166 pneumonia patients.
Sensitivity was 97.5 %, specificity 84.1 % and AUC 0.974
when PCR was compared with culture. As these results were
derived by comparing analyses on same samples they are dif-
ficult to compare with the present results. Of interest in this
study confirmatory fucK PCR was performed to establish the
specificity of the method [21].
Lack of a true gold standard
Aweakness of this study and other comparable studies is the
relatively low sensitivity of the reference methods used for
comparison. This decreases sensitivity and specificity and in
turn affects AUC [32]. In addition, antibiotic exposure may
increase discrepancy between PCR and culture-based results.
The improved performance of rtPCR among patients without
recent antibiotic use supports this possibility.
Value of negative results
For both pathogens specificity and NPV were excellent. The
application of rtPCR is not constrained to ascertaining etiolo-
gy but may also be useful for decreasing the clinical likelihood
of disease due to certain pathogens. Negative results may also
have increased validity in the setting ofmultiplex-PCRwhen a
clinically reasonable alternative pathogen has been identified.
It is doubtful such an interpretation can be made in severely ill
patients but might assist in avoiding antimicrobials in certain
situations, such as in patients with less severe disease and a
high probability of viral infection.
Conclusions
This study compares rtPCR analysis of oropharyngeal sam-
ples with conventional testing for diagnosis of bacterial pneu-
monia caused by SP or HI. Due to the high inclusion rate the
results of this study may be more applicable to other settings
than most studies of this nature. The results are comparable to
previous studies analyzing high quality sputum. Utilizing dif-
ferent Ct values to quantify positive rtPCR results can assist in
discerning colonization from infection caused by SP and HI in
the setting of pneumonia. Further studies are required to test
Fig. 1 Receiver operating characteristic (ROC) curves comparing Ct results from real-time PCR to results from conventional microbiological testing for
S. pneumoniae (left) (AUC = 0.653; 95 % CI 0.508–0.799) and H. influenzae (right) (AUC = 0.859; 95 % CI 0.722–0.997)
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these findings and identify patient groups most likely to ben-
efit from these tests.
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